Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 10505724)

Published in Dig Dis Sci on September 01, 1999

Authors

C Valle1, F Broglia, A Pistorio, C Tinelli, M Perego

Author Affiliations

1: Department of Internal Medicine and Epidemiology and Biometrics Service, IRCCS Policlinico S. Matteo, University of Pavia, Italy.

Articles citing this

Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35

Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2013) 2.96

Studying the overlap between IBS and GERD: a systematic review of the literature. Dig Dis Sci (2006) 1.04

Reflux oesophagitis in adult coeliac disease: beneficial effect of a gluten free diet. Gut (2003) 1.00

Epidemiological features of gastro-esophageal reflux disease in Iran based on general population. Gastroenterol Hepatol Bed Bench (2012) 0.87

Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One (2010) 0.87

Severely disordered esophageal peristalsis is not a contraindication to laparoscopic Nissen fundoplication. Surg Endosc (2006) 0.85

Prevalence of dysphagia in patients with gastroesophageal reflux in Germany. Dysphagia (2008) 0.80

A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. Dig Dis Sci (2006) 0.79

The role of GABA(A) receptors in the control of transient lower oesophageal sphincter relaxations in the dog. Br J Pharmacol (2008) 0.79

Gastroesophageal reflux disease and non-esophageal cancer. World J Gastroenterol (2015) 0.78

Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting. Clin Epidemiol (2013) 0.78

Gastro esophageal reflux disease is associated with absence from work: results from a prospective cohort study. World J Gastroenterol (2005) 0.77

pH Impedance vs. traditional pH monitoring in clinical practice: an outcome study. J Gastroenterol (2015) 0.77

Zero-Inflated Models for Identifying Relationships Between Body Mass Index and Gastroesophageal Reflux Symptoms: A Nationwide Population-Based Study in China. Dig Dis Sci (2016) 0.75

Articles cited by this

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98

Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60

Symptoms in gastro-oesophageal reflux disease. Lancet (1990) 4.10

Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis (1976) 3.71

Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion (1992) 2.40

Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol (1987) 1.97

Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med (1995) 1.97

Heartburn and globus in apparently healthy people. Can Med Assoc J (1982) 1.58

Computerized 24-hour ambulatory esophageal pH monitoring and esophagogastroduodenoscopy in the reflux patient. A comparative study. Ann Surg (1984) 1.44

The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol (1991) 1.26

Epidemiology of oesophageal reflux disease. Scand J Gastroenterol Suppl (1989) 1.20

Epidemiology of gastro-esophageal reflux disease. World J Surg (1992) 1.06

Gastro-oesophageal reflux in the irritable bowel syndrome. Gut (1986) 0.92

[Epidemiology of intestinal functional disorders in an apparently healthy population]. Gastroenterol Clin Biol (1986) 0.90

Hospital discharges resulting from esophagitis among Medicare beneficiaries. Dig Dis Sci (1994) 0.85

Determinants of symptoms suggestive of gastroesophageal reflux disease in the elderly. Scand J Gastroenterol (1993) 0.79

The prevalence of gastro-oesophageal reflux disease. Scand J Gastroenterol Suppl (1995) 0.79

Manometric oesophageal function, acid perfusion test and symptomatology in a 55-year-old general population. Clin Physiol (1981) 0.77

Functional gastrointestinal symptoms in a Wellington community sample. N Z Med J (1990) 0.76

[Epigastric pain and regurgitation: descriptive epidemiology in a representative sample of the adult population of France]. Gastroenterol Clin Biol (1988) 0.75

Epidemiology and natural history of gastro-esophageal reflux. Rev Med Chir Soc Med Nat Iasi (1995) 0.75

Articles by these authors

The transition state transcription regulator abrB of Bacillus subtilis is a DNA binding protein. EMBO J (1989) 3.31

Dynamic, mitotic-like behavior of a bacterial protein required for accurate chromosome partitioning. Genes Dev (1997) 3.28

Multiple histidine kinases regulate entry into stationary phase and sporulation in Bacillus subtilis. Mol Microbiol (2000) 3.25

Transcription of Bacillus subtilis subtilisin and expression of subtilisin in sporulation mutants. J Bacteriol (1988) 3.20

Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol (2001) 2.55

Sequence and analysis of the genetic locus responsible for surfactin synthesis in Bacillus subtilis. Mol Microbiol (1993) 2.35

Central diabetes insipidus in children and young adults. N Engl J Med (2000) 1.97

Location of the targets of the hpr-97, sacU32(Hy), and sacQ36(Hy) mutations in upstream regions of the subtilisin promoter. J Bacteriol (1988) 1.74

Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients. Ann Oncol (2010) 1.73

Headache attributed to infection: observations on the IHS classification (ICHD-II). Cephalalgia (2006) 1.69

Differential processing of propeptide inhibitors of Rap phosphatases in Bacillus subtilis. J Bacteriol (2000) 1.66

Control of the initiation of sporulation in Bacillus subtilis by a phosphorelay. Res Microbiol (1992) 1.64

The transition state transcription regulator AbrB of Bacillus subtilis is autoregulated during vegetative growth. Mol Microbiol (1989) 1.59

A novel histidine kinase inhibitor regulating development in Bacillus subtilis. Genes Dev (1997) 1.58

Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) (2006) 1.55

The role of functional respiratory tests in predicting pneumothorax during lung needle biopsy. Chest (1996) 1.52

Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis. Am J Med (2001) 1.49

Control of SIV rebound through structured treatment interruptions during early infection. Science (2000) 1.48

Structural alterations in the Bacillus subtilis Spo0A regulatory protein which suppress mutations at several spo0 loci. J Bacteriol (1990) 1.48

Immunogenicity of hepatitis B vaccine in term and preterm infants. Acta Paediatr (1998) 1.45

UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen. Oncology (2008) 1.43

Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study. Ital J Gastroenterol Hepatol (1997) 1.40

D-alanine deprivation of Bacillus subtilis teichoic acids is without effect on cell growth and morphology but affects the autolytic activity. Microb Drug Resist (1996) 1.31

Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol (1995) 1.29

Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol (2000) 1.25

A negative regulator linking chromosome segregation to developmental transcription in Bacillus subtilis. Mol Microbiol (1998) 1.25

Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium (2008) 1.23

An Italian national multicenter study for the definition of reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults. Haematologica (1999) 1.23

Alanine mutants of the Spo0F response regulator modifying specificity for sensor kinases in sporulation initiation. Mol Microbiol (1999) 1.22

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. J Infect Dis (1999) 1.21

Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis (2002) 1.19

Bacillus subtilis mutS mutL operon: identification, nucleotide sequence and mutagenesis. Microbiology (1996) 1.18

ScoC regulates peptide transport and sporulation initiation in Bacillus subtilis. J Bacteriol (1999) 1.17

Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab (2007) 1.17

Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab (1999) 1.14

Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. Eur J Endocrinol (2005) 1.14

Dissection of the functional and structural domains of phosphorelay histidine kinase A of Bacillus subtilis. J Bacteriol (2001) 1.14

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology (1996) 1.12

Egg allergy: the relevance of molecular-based allergy diagnostics. Clin Exp Allergy (2014) 1.10

Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma. Br J Cancer (2000) 1.09

"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med (1995) 1.08

Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J (2001) 1.08

Etiology and age incidence of precocious puberty in girls: a multicentric study. J Pediatr Endocrinol Metab (2000) 1.07

Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. Clin Exp Rheumatol (1999) 1.04

MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J (2000) 1.04

Effectiveness of risperidone in Huntington chorea patients. J Clin Psychopharmacol (1999) 1.03

The Bacillus subtilis genes for ribonucleotide reductase are similar to the genes for the second class I NrdE/NrdF enzymes of Enterobacteriaceae. Microbiology (1996) 1.01

First report of the Italian register for diffuse infiltrative lung disorders (RIPID). Monaldi Arch Chest Dis (2001) 1.01

Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol Suppl (1994) 1.01

Characterization of interactions between a two-component response regulator, Spo0F, and its phosphatase, RapB. Biochemistry (1998) 1.01

Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. Eur J Clin Microbiol Infect Dis (2001) 1.01

Myoelectric manifestations of muscle changes in stroke patients. Arch Phys Med Rehabil (2001) 1.00

Holter monitoring in AL amyloidosis: prognostic implications. Pacing Clin Electrophysiol (2001) 0.98

Fetal spine ossification: the gender and individual differences illustrated by ultrasonography. Ultrasound Med Biol (2005) 0.98

Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol (1994) 0.97

Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet (2005) 0.97

Cancer mortality in an Italian rubber factory. Br J Ind Med (1987) 0.97

Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis. J Rheumatol (2001) 0.96

Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers. Drugs Exp Clin Res (1988) 0.96

Different clinical presentation of interstitial cystitis syndrome. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.96

Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies. Clin Vaccine Immunol (2009) 0.96

Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum (2000) 0.96

Early immunisation with hepatitis B vaccine: a five-year study. Vaccine (2000) 0.96

Helicobacter colonization and histopathological profile of chronic gastritis in patients with or without dyspepsia, mucosal erosion and peptic ulcer: a morphological approach to the study of ulcerogenesis in man. Virchows Arch A Pathol Anat Histopathol (1992) 0.95

Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2. Eur J Cancer (1991) 0.95

Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis. J Hosp Infect (2007) 0.94

Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus. Genes Immun (2001) 0.94

Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Ann Rheum Dis (2007) 0.94

Discordance between physician's and parent's global assessments in juvenile idiopathic arthritis. Rheumatology (Oxford) (2006) 0.93

Discordance between proxy-reported and observed assessment of functional ability of children with juvenile idiopathic arthritis. Rheumatology (Oxford) (2001) 0.93

Altered intercellular glycoconjugates and dilated intercellular spaces of esophageal epithelium in reflux disease. Virchows Arch (2000) 0.93

IL-10 and IL-4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients. Clin Exp Immunol (1998) 0.92

The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. Ann Rheum Dis (2007) 0.92

Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. Hepatology (1999) 0.92

Choosing the best rehabilitation treatment for Bell's palsy. Eur J Phys Rehabil Med (2012) 0.92

Glutamate synthase genes of the diazotroph Azospirillum brasilense. Cloning, sequencing, and analysis of functional domains. J Biol Chem (1993) 0.91

Lung function abnormalities after bone marrow transplantation in children: has the trend recently changed? Chest (2001) 0.91

Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus (2006) 0.91

Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study. J Cardiovasc Pharmacol (1992) 0.90

Five-year follow-up of a cognitive-behavioural lifestyle multidisciplinary programme for childhood obesity outpatient treatment. Eur J Clin Nutr (2007) 0.90

The Italian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol (2001) 0.89

The Paediatric Rheumatology International Trials Organization (PRINTO). Lupus (2007) 0.89

Impact of allergic rhinitis on asthma: effects on spirometric parameters. Allergy (2007) 0.89

Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. Am J Gastroenterol (1996) 0.89

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes. Diabetes Obes Metab (2009) 0.88

HLA-A*01 is associated with late onset of Alzheimer's disease in Italian patients. Int J Immunopathol Pharmacol (2010) 0.87

A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis. Ann Rheum Dis (2007) 0.87

Serum liver enzymes in Turner syndrome. Eur J Pediatr (2000) 0.87

Benzodiazepine receptors and diazepam binding inhibitor: a possible link between stress, anxiety and the immune system. Psychoneuroendocrinology (1993) 0.86

Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. Am J Respir Crit Care Med (1996) 0.86

Deficiency of INFgamma producing cells in adenoids of children exposed to passive smoke. Int J Immunopathol Pharmacol (2006) 0.86

Immunological effects of bevacizumab-based treatment in metastatic colorectal cancer. Oncology (2011) 0.86

Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment. Acta Psychiatr Scand (1990) 0.86

Responsiveness of clinical measures to flare of disease activity in juvenile idiopathic arthritis. Clin Exp Rheumatol (2005) 0.86

The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. J Pediatr (1999) 0.86

Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism. J Clin Endocrinol Metab (2001) 0.86

Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine. Vaccine (1998) 0.85